newsfilter
← Latest News
Business Wire·

Dr. Reddy's Laboratories Launches its Generic Semaglutide Injection in Canada

The launch follows Dr. Reddy's receipt of the Notice of Compliance (NOC) from Health Canada on April 28th, 2026, marking the company's readiness to serve Canadian patients Dr. Reddy's is the first company to receive